Laryngeal edema and metabolic acidosis after Omnicide® ingestion

Clinical Toxicology

Volumn 46, Issue 9, 2008, Pages 858-860

  Perera, P M S ^a,c   Kularathne, K ^a,b   Gawarammana, I B ^a,b  

^a South Asian Clinical Toxicologic Research Collaboration   (Sri Lanka)

^b Consultant Physician Teaching Hospital ^*  (Sri Lanka)

^c UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

Glutaraldehyde; Laryngeal oedema; Metabolic acidosis

Indexed keywords

AMPICILLIN; BICARBONATE; GLUTARALDEHYDE; HYDROCORTISONE; INFUSION FLUID; METRONIDAZOLE; QUATERNARY AMMONIUM DERIVATIVE;

ADULT; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; ELECTROCARDIOGRAM; ENDOSCOPY; FEMALE; HUMAN; INTESTINE LAVAGE; LABORATORY TEST; LARYNX EDEMA; METABOLIC ACIDOSIS; PHYSICAL EXAMINATION; RESPIRATORY DISTRESS; THORAX RADIOGRAPHY; VITAL SIGN;

EID: 55949093768     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650801986703     Document Type: Article

References (26)

1. Beauchamp Jr RO, St Clair MB, Fennell TR, Clarke DO, Morgan KT, Kari FW. A critical review of the toxicology of glutaraldehyde. Critical Reviews in Toxicology 1992; 22(3-4):143-174.
2. Vergnes JS, Ballantyne B. Genetic toxicology studies with glutaraldehyde. J Appl Toxicol 2002; 22(1):45-60.
3. Anadol D, Ozcelik U, Kiper N, Gocmen A. Chemical pneumonia caused by glutaraldehyde. Pediatr Int 2001; 43(6):701-702.
4. West AB, Kuan SF, Bennick M, Lagarde S. Glutaraldehyde colitis following endoscopy: clinical and pathological features and investigation of an outbreak. Gastroenterology 1995; 108(4):1250-1255.
5. Zissin R, Gayer G, Maor-Kendler Y. CT findings of glutaraldehyde colitis: a report of two cases. Clinical Radiology 1999; 54(2):123-125.
6. Takigawa T, Endo Y. Effects of glutaraldehyde exposure on human health. Journal of Occupational Health 2006; 48(2):75-87.
7. Vyas A, Pickering CA, Oldham LA, Francis HC, Fletcher AM, Merrett T, Niven RM. Survey of symptoms, respiratory function, and immunology and their relation to glutaraldehyde and other occupational exposures among endoscopy nursing staff. Occup Environ Med 2000; 57(11):752-759.
8. Smedley J, Cullinan P, Frew A, Newman-Taylor A, Coggon D. Work related respiratory symptoms in radiographers. Occup Environ Med 1999; 56(9):646.
9. Smedley J, Inskip H, Wield G, Coggon D. Work related respiratory symptoms in radiographers. Occup Environ Med 1996; 53(7):450-454.
10. Anees W, Robertson AS, Burge PS. Glutaraldehyde induced asthma in endoscopy nursing staff. Occup Environ Med 2001, 58(8):544.
11. Leung HW. Ecotoxicology of glutaraldehyde: review of environmental fate and effects studies. Ecotoxicol Environ Saf 2001; 49(1):26-39.
12. Gad SC. A scheme for the prediction and ranking of relative potencies of dermal sensitizers based on data from several systems. J Appl Toxicol 1988; 8(5):361-368.
13. Ballantyne B, Myers RC. The acute toxicity and primary irritancy of glutaraldehyde solutions. Vet Hum Toxicol 2001; 43(4):193-202.
14. Millington DS, Roe CR, Maltby DA. Characterization of new diagnostic acylcarnitines in patients with beta-ketothiolase deficiency and glutaric aciduria type I using mass spectrometry. Biomedical & environmental mass spectrometry 1987; 14(12):711-716.
15. Henderson HE, Balla R, de Jong G, Piek CJ, Mienie LJ, Erasmus E. Postnatal and antenatal laboratory diagnosis of glutaric aciduria II in a South African family. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1987; 71(9):589-591.
16. Hostetler MA, Arnold GL, Mooney R, Bennett MJ, Rinaldo P, Roe CR. Hypoketotic hypoglycemic coma in a 21-month-old child. Annals of emergency medicine 1999; 34(3):394-398.
17. Coude FX, Ogier H, Charpentier C, Thomassin G, Checoury A, Amedee-Manesme O, Saudubray JM, Frezal J. Neonatal glutaric aciduria type II: an X-linked recessive inherited disorder. Human genetics 1981, 59(3):263-265.
18. Kupfer A, Aeschlimann C, Wermuth B, Cerny T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet 1994; 343(8900):763-764.
19. Ferreira Gda C, Schuck PF, Viegas CM, Tonin A, Latini A, Dutra-Filho CS, Wyse AT, Wannmacher CM, Vargas CR, Wajner M. Energy metabolism is compromised in skeletal muscle of rats chronically-treated with glutaric acid. Metabolic brain disease 2007; 22(1):111-123.
20. Whelan DT, Hill R, Ryan ED, Spate M. L-Glutaric acidemia: investigation of a patient and his family. Pediatrics 1979, 63(1):88-93.
21. Franklin P, Dingle P, Stick S. Raised exhaled nitric oxide in healthy children is associated with domestic formaldehyde levels. American journal of respiratory and critical care medicine 2000; 161(5):1757-1759.
22. Popa V, Teculescu D, Stanescu D, Gavrilescu N. Bronchial asthma and asthmatic bronchitis determined by simple chemicals. Diseases of the Chest 1969; 56(5):395-402.
23. Takeuchi N, Takikawa Y, Shibuya N. Actions of benzalkonium chloride as a potent depressant at the neuromuscular junction. Neuropharmacology 1993; 32(4):377-385.
24. Gloxhuber C. Toxicological properties of surfactants. Archives of Toxicology 1974; 32(4):245-270.
25. August PJ. Cutaneous necrosis due to cetrimide application. British Medical Journal 1975, 1(5949):70.
26. van Berkel M, de Wolff FA. Survival after acute benzalkonium chloride poisoning. Human toxicology 1988; 7(2):191-193.